JY
AUTL

Jeff Yass’s Autolus Therapeutics AUTL Stock Holding History

Jeff Yass’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Sell
177,232
-221,911
-56% -$348K ﹤0.01% 11177
2026
Q1 		$551K Sell
399,143
-199,844
-33% -$304K ﹤0.01% 9409
2025
Q4 		$1.19M Buy
598,987
+363,159
+154% +$558K ﹤0.01% 6791
2025
Q3 		$384K Buy
235,828
+15,259
+7% +$29.8K ﹤0.01% 9566
2025
Q2 		$503K Buy
220,569
+153,514
+229% +$254K ﹤0.01% 9166
2025
Q1 		$104K Sell
67,055
-3,836
-5% -$7.79K ﹤0.01% 11516
2024
Q4 		$167K Buy
70,891
+50,187
+242% +$170K ﹤0.01% 10930
2024
Q3 		$75.2K Buy
20,704
+301
+1% +$1.2K ﹤0.01% 11198
2024
Q2 		$71K Sell
20,403
-50,816
-71% -$219K ﹤0.01% 11239
2024
Q1 		$454K Buy
71,219
+18,215
+34% +$114K ﹤0.01% 8731
2023
Q4 		$341K Buy
+53,004
New +$202K ﹤0.01% 9557
2023
Q2 		– Sell
-38,947
Closed -$92.4K – 12031
2023
Q1 		$71.7K Buy
38,947
+18,744
+93% +$36.6K ﹤0.01% 11518
2022
Q4 		$38.4K Buy
20,203
+8,063
+66% +$20.4K ﹤0.01% 11534
2022
Q3 		$26K Sell
12,140
-4,477
-27% -$13.3K ﹤0.01% 12505
2022
Q2 		$47K Buy
+16,617
New +$50.6K ﹤0.01% 12008
2022
Q1 		– Sell
-15,670
Closed -$65.9K – 12944
2021
Q4 		$81K Buy
+15,670
New +$94K ﹤0.01% 12274

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jeff Yass's AUTL Position: Q2 2026 in Review

Jeff Yass reduced its Autolus Therapeutics (AUTL) stake by 56% in Q2 2026, selling an estimated $348K and leaving 177,232 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #11177.

Jeff Yass first reported a position in AUTL in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.19M in Q4 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Jeff Yass held 177,232 shares of Autolus Therapeutics worth $284K as of Q2 2026.
  • Jeff Yass sold 221,911 Autolus Therapeutics shares in Q2 2026, an estimated $348K.
  • Autolus Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11177 holding.
  • Jeff Yass first reported a position in Autolus Therapeutics in Q4 2021 and has held it in 16 quarters since.
  • Jeff Yass's Autolus Therapeutics position peaked at $1.19M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.